Sensible Medical Innovations
Noninvasive Lung Fluid Monitoring and Management
StartupSensible Medical Innovations is a Netanya-based startup in the Health Tech & Life Sciences sector, established in 2007. Noninvasive Lung Fluid Monitoring and Management. The company has raised a total of $37.56M across 5 funding rounds, currently at the Mature stage. Sensible Medical Innovations was founded by Amir Ronen, Amir Saroka, Shlomi Bergida, Nadav Mizrahi, Dan Rappaport . Key investors include Medicure Inc., Genesis Partners, SCP Vitalife, among 4 total investors. The company has 11-50 employees. Core technologies: Semiconductors & Electronics, Wearables, Sensing, Communications, Radio Frequency, IOT, Simulation & Imaging.
With $37.56M in total funding, Sensible Medical Innovations is a Mature-stage company operating in Health Tech & Life Sciences. The company follows a B2B2C/B2B/B2C business model. Product stage: Released.
- StageMature
- ProductReleased
- ModelB2B2C, B2B, B2C
- Employees11-50
- HQNetanya
- DistrictCenter District
- Last Round$61K
- Medicure Inc.
- Genesis Partners
- SCP Vitalife
4 investors total
Amir RonenCo-founder & CEO
Amir SarokaCo-founder & CTO
Shlomi BergidaCo-founder & VP Products
Nadav MizrahiCo-founder & VP R&D
Dan Rappaport Co-founder (No longer with the company)
9 articles covered by sources including www.prnewswire.com,
www.calcalistech.com,
www.biospectrumindia.com,
wexnermedical.osu.edu,
www.conehealth.com.
What does Sensible Medical Innovations do?
Sensible Medical Innovations has developed the ReDS medical radar technology, which originated from the defense industrys see through walls technology. ReDS is designed to monitor and manage patients with fluid management problems, including patients living with heart failure (HF), taking diuretic medication, or recovering from an event related to coronary artery disease. ReDS is intended for use by qualified healthcare practitioners and by patients under the direction of a physician in hospitals, hospital-type facilities, and the home environment. In a pilot study, ReDS-guided HF management reduced the number of HF-related rehospitalizations by approximately 80%. The company is headquartered in Israel with commercial offices in the United States. In August 2015, Sensible Medicals noninvasive thoracic fluid status monitor was cleared for market in the United States.
How much funding has Sensible Medical Innovations raised?
Sensible Medical Innovations has raised $37.56M in total funding across 5 rounds. The company is currently at the Mature stage. Key investors include Medicure Inc., Genesis Partners, SCP Vitalife.
Who founded Sensible Medical Innovations?
Sensible Medical Innovations was founded in 2007 by Amir Ronen (Co-founder & CEO), Amir Saroka (Co-founder & CTO), Shlomi Bergida (Co-founder & VP Products), Nadav Mizrahi (Co-founder & VP R&D), Dan Rappaport (Co-founder (No longer with the company)).
What sector is Sensible Medical Innovations in?
Sensible Medical Innovations operates in Health Tech & Life Sciences, Digital Healthcare, Patient Remote Monitoring, with core technologies in Semiconductors & Electronics, Wearables, Sensing, Communications, Radio Frequency, IOT, Simulation & Imaging. Target customers: Healthcare & Life Sciences, Healthcare, Providers.
Where is Sensible Medical Innovations located?
Sensible Medical Innovations is based in Meir Ariel St 6, Netanya, Israel, Center District. The company also has offices abroad.